Antidepressants on Multiple Sclerosis: A Review of In Vitro and In Vivo Models

BACKGROUND: Increased prevalence of depression has been observed among patients with multiple sclerosis (MS) and correlated with the elevated levels of proinflammatory cytokines and the overall deregulation of monoaminergic neurotransmitters that these patients exhibit. Antidepressants have proved e...

Descripción completa

Detalles Bibliográficos
Autores principales: Stamoula, Eleni, Siafis, Spyridon, Dardalas, Ioannis, Ainatzoglou, Alexandra, Matsas, Alkis, Athanasiadis, Theodoros, Sardeli, Chrysanthi, Stamoulas, Konstantinos, Papazisis, Georgios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173210/
https://www.ncbi.nlm.nih.gov/pubmed/34093579
http://dx.doi.org/10.3389/fimmu.2021.677879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173210/
https://www.ncbi.nlm.nih.gov/pubmed/34093579
http://dx.doi.org/10.3389/fimmu.2021.677879

Ejemplares similares